Years of experience: 27
PartnerInvestor & VCC-level ExecutiveSales & BizDevCEOConsulting
Trust Score
Exceptionally trusted; proven professional excellence.
Soren's Career Path
Dec. 2024 -Feb. 2025
Axcynsis TherapeuticsChief Business Officer
New York City Metropolitan AreaLeading Axcynsis' $40M series A fundraising and supporting partnering of its proprietary, first-in-class AxcynDOT payload and IND-stage ADC therapeutics
May. 2023 -Apr. 2024
PILA PHARMADirector Board of Directors
Malmö, Skåne County, SwedenDirector on the board with special insights into orphan drug development and US opportunities
Dec. 2020 -Apr. 2024
DeckTherapeutics, Inc.Chief Executive Officer
New York City Metropolitan AreaLed Columbia University spinout DeckTherapeutics on its mission to pioneer neuroprotection using intravenous omega-3 diglyceride therapeutics. Secured funding from two institutional investors and a non-dilutive grant from the Bill & Melinda Gates Foundation. Oversaw the progression of the lead asset to late preclinical stage.